Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Active prescription of low-dose aspirin during or prior to hospitalization and mortality in COVID-19: A systematic review and meta-analysis of adjusted effect estimates
Januar Wibawa Martha, Raymond Pranata, Michael Anthonius Lim, et al.
International Journal of Infectious Diseases (2021) Vol. 108, pp. 6-12
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Use of non-steroidal anti-inflammatory drugs and adverse outcomes during the COVID-19 pandemic: A systematic review and meta-analysis
Qi Zhou, Siya Zhao, Lidan Gan, et al.
EClinicalMedicine (2022) Vol. 46, pp. 101373-101373
Open Access | Times Cited: 38
The effects of aspirin on the outcome of COVID-19: A systematic review and meta-analysis
Indra Wijaya, Rizky Andhika, Ian Huang, et al.
Clinical Epidemiology and Global Health (2021) Vol. 12, pp. 100883-100883
Open Access | Times Cited: 45
The 125th Anniversary of Aspirin—The Story Continues
Oliver Werz, Hans Stettler, Christoph Theurer, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 437-437
Open Access | Times Cited: 6
Atherosclerosis, Cardiovascular Disease, and COVID-19: A Narrative Review
Carles Vilaplana-Carnerero, Maria Giner‐Soriano, Ángela Domı́nguez, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1206-1206
Open Access | Times Cited: 14
Ivermectin and mortality in patients with COVID-19: A systematic review, meta-analysis, and meta-regression of randomized controlled trials
Ahmad Fariz Malvi Zamzam Zein, Catur Setiya Sulistiyana, Wilson Matthew Raffaelo, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2021) Vol. 15, Iss. 4, pp. 102186-102186
Open Access | Times Cited: 31
Antiplatelet therapy for patients with COVID-19: Systematic review and meta-analysis of observational studies and randomized controlled trials
Xiaolong Zong, Xiao Wang, Yaru Liu, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 19
COVID-19 and Pulmonary Angiogenesis: The Possible Role of Hypoxia and Hyperinflammation in the Overexpression of Proteins Involved in Alveolar Vascular Dysfunction
Anna Flavia Ribeiro Santos Miggiolaro, Felipe Silva, David Batista Wiedmer, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 706-706
Open Access | Times Cited: 10
Does aspirin have an effect on risk of death in patients with COVID-19? A meta-analysis
Shaodi Ma, Wanying Su, Chenyu Sun, et al.
European Journal of Clinical Pharmacology (2022) Vol. 78, Iss. 9, pp. 1403-1420
Open Access | Times Cited: 17
Dipeptidyl peptidase-4 (DPP-IV) inhibitor was associated with mortality reduction in COVID-19 — A systematic review and meta-analysis
Ahmad Fariz Malvi Zamzam Zein, Wilson Matthew Raffaello
Primary care diabetes (2021) Vol. 16, Iss. 1, pp. 162-167
Open Access | Times Cited: 21
Aspirin as an Adjunctive Pharmacologic Therapy Option for COVID-19: Anti-Inflammatory, Antithrombotic, and Antiviral Effects All in One Agent
Udaya S. Tantry, Karsten Schrör, Eliano Pio Navarese, et al.
Journal of Experimental Pharmacology (2021) Vol. Volume 13, pp. 957-970
Open Access | Times Cited: 21
Aspirin and Infection: A Narrative Review
Stefano Di Bella, Roberto Luzzati, Luigi Principe, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 263-263
Open Access | Times Cited: 14
To Anticoagulate or Not to Anticoagulate in COVID-19: Lessons after 2 Years
John G. Rizk, Aashish Gupta, Jose G. Lazo, et al.
Seminars in Thrombosis and Hemostasis (2022) Vol. 49, Iss. 01, pp. 062-072
Closed Access | Times Cited: 14
School resources and effective implementation of e-Learning in secondary schools in Kasese Municipality, Uganda
Tobia Karaha Kyomuhendo, Wilson Mugizi, Joseph Rwothumio, et al.
Interdisciplinary Journal of Education Research (2024) Vol. 6, pp. 1-16
Open Access | Times Cited: 2
Clinical update on COVID-19 for the emergency and critical care clinician: Medical management
Brit Long, Summer Chavez, Brandon M Carius, et al.
The American Journal of Emergency Medicine (2022) Vol. 56, pp. 158-170
Open Access | Times Cited: 13
Effect of colchicine on mortality in patients with COVID-19 – A systematic review and meta-analysis
Ahmad Fariz Malvi Zamzam Zein, Wilson Matthew Raffaello
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2022) Vol. 16, Iss. 2, pp. 102395-102395
Open Access | Times Cited: 12
Effects of non‐steroidal anti‐inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID‐19
Milena Sokołowska, G. Enrico Rovati, Zuzana Diamant, et al.
Allergy (2022) Vol. 77, Iss. 8, pp. 2337-2354
Open Access | Times Cited: 12
Risk Factors for Postdischarge Major Thromboembolism and Mortality in Hospitalized Patients with COVID-19 with Cardiovascular Comorbidities: Insights from the CORE-19 Registry
Dimitrios Giannis, Mark Goldin, Husneara Rahman, et al.
Thrombosis and Haemostasis (2023) Vol. 123, Iss. 11, pp. 1089-1099
Closed Access | Times Cited: 7
Associations between the use of aspirin or other antiplatelet drugs and all-cause mortality among patients with COVID-19: A meta-analysis
Wanting Su, Miao He, Zhaotian Guo, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10
Cardiovascular Complications in Coronavirus Disease 2019—Pathogenesis and Management
Marcos I. Restrepo, Judith Marín‐Corral, Juan José Berenguer Rodríguez, et al.
Seminars in Respiratory and Critical Care Medicine (2023) Vol. 44, Iss. 01, pp. 021-034
Closed Access | Times Cited: 5
Acetylsalicylic Acid Compared with Enoxaparin for the Prevention of Thrombosis and Mechanical Ventilation in COVID-19 Patients: A Retrospective Cohort Study
Heba Wagih Abdelwahab, Shaker Wagih Shaltout, Hazem A. Sayed Ahmed, et al.
Clinical Drug Investigation (2021) Vol. 41, Iss. 8, pp. 723-732
Open Access | Times Cited: 13
Effect of antiplatelet therapy after COVID-19 diagnosis: A systematic review with meta-analysis and trial sequential analysis
Hong Duo, Mengying Jin, Yanwei Yang, et al.
PLoS ONE (2024) Vol. 19, Iss. 2, pp. e0297628-e0297628
Open Access | Times Cited: 1
Home pharmacological therapy in early COVID‐19 to prevent hospitalization and reduce mortality: Time for a suitable proposal
Sergio Pandolfi, Salvatore Chirumbolo, Giovanni Ricevuti, et al.
Basic & Clinical Pharmacology & Toxicology (2021) Vol. 130, Iss. 2, pp. 225-239
Open Access | Times Cited: 11
COVID-19 thromboprophylaxis. New evidence
Raquel Ferrandis, P. Sierra, A. Gómez‐Luque
Revista Española de Anestesiología y Reanimación (English Edition) (2023) Vol. 71, Iss. 1, pp. 34-47
Closed Access | Times Cited: 3
Treatments Associated with Lower Mortality among Critically Ill COVID-19 Patients: A Retrospective Cohort Study
Xu Zhao, Chan Gao, Feng Dai, et al.
Anesthesiology (2021) Vol. 135, Iss. 6, pp. 1076-1090
Open Access | Times Cited: 7
Does admission acetylsalicylic acid uptake in hospitalized COVID-19 patients have a protective role? Data from the Spanish SEMI-COVID-19 Registry
Francesç Formiga, Manuel Rubio‐Rivas, José María Mora‐Luján, et al.
Internal and Emergency Medicine (2021) Vol. 17, Iss. 3, pp. 761-775
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top